The Journal of dermatological treatment · 2025
Flumethasone-salicylic acid cream effectively flattened verrucous epidermal nevus: a case report.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jiang Yu, Li Wei, Deng Shilin, Li Qian, Liu Wenyan, Ye Hui, Liang Jingyao, Zhang Xibao
Аннотация
OBJECTIVES: To assess the efficacy and safety of topical compound flumethasone pivalate-salicylic acid cream for verrucous epidermal nevus (VEN), a benign keratinocytic hamartoma with limited current treatment options.
METHODS: A 25-year-old male with 20-year VEN (right buttock/lower limb plaques) was treated with the compound cream (0.2 mg flumethasone pivalate + 30 mg salicylic acid/gram) twice daily for over 2 months, followed by 14-week follow-up.
RESULTS: Lesions showed progressive thinning, significantly reduced hyperpigmentation, and no adverse events. The Dermatology Life Quality Index score improved from 13 to 3, with no recurrence at follow-up.
CONCLUSIONS: Topical compound flumethasone pivalate-salicylic acid cream is effective and safe for VEN, potentially via inhibiting abnormal keratinocyte proliferation, serving as a practical topical option.
METHODS: A 25-year-old male with 20-year VEN (right buttock/lower limb plaques) was treated with the compound cream (0.2 mg flumethasone pivalate + 30 mg salicylic acid/gram) twice daily for over 2 months, followed by 14-week follow-up.
RESULTS: Lesions showed progressive thinning, significantly reduced hyperpigmentation, and no adverse events. The Dermatology Life Quality Index score improved from 13 to 3, with no recurrence at follow-up.
CONCLUSIONS: Topical compound flumethasone pivalate-salicylic acid cream is effective and safe for VEN, potentially via inhibiting abnormal keratinocyte proliferation, serving as a practical topical option.